[Effect of multidrug resistant associated protein 4 overexpression on lipopolysaccharide-induced vascular endothelial

Wenfang Xia1, Huanming Zhang, Yanlei Zheng

  • 1Department of Critical Care Medicine, People's Hospital of Wuhan University, Wuhan 430060, Hubei, China. Corresponding author: Xia Wenfang,

Abstract

Insights

Multidrug resistance protein 4 (MRP4) overexpression worsens lipopolysaccharide (LPS)-induced hyperpermeability in pulmonary microvascular endothelial cells (PMVECs). This occurs by lowering cyclic adenosine monophosphate (cAMP) and reducing intercellular junction proteins.

Area of Science:

  • Endothelial Biology
  • Molecular Mechanisms of Disease
  • Pharmacology

Background:

  • Lipopolysaccharide (LPS) triggers vascular endothelial hyperpermeability, a key factor in inflammatory conditions.
  • Multidrug resistance protein 4 (MRP4) is implicated in cellular transport and inflammatory responses.

Purpose of the Study:

  • To investigate the impact of MRP4 overexpression on LPS-induced hyperpermeability in rat pulmonary micro-vascular endothelial cells (PMVECs).
  • To elucidate the molecular mechanisms underlying MRP4's effect on endothelial barrier function.

Main Methods:

  • PMVECs were cultured and divided into LPS, Ad-shRNA (control), and Ad-MRP4 (MRP4 overexpression) groups.
  • Endothelial permeability, intracellular cyclic adenosine monophosphate (cAMP) levels, F-actin distribution, and protein expression (MRP4, β-catenin, VE-cad, ZO-1) were assessed.
  • Transwell assays, ELISA, laser confocal microscopy, and Western blotting were employed.

Main Results:

  • MRP4 overexpression significantly increased endothelial permeability and decreased intracellular cAMP levels in PMVECs stimulated with LPS.
  • LPS challenge induced stress fiber formation, which was more pronounced and irregular in PMVECs overexpressing MRP4.
  • MRP4 overexpression led to decreased expression of β-catenin, vascular endothelium-cadherin (VE-cad), and ZO-1.

Conclusions:

  • MRP4 overexpression exacerbates LPS-induced vascular endothelial hyperpermeability.
  • This effect is mediated by decreased intracellular cAMP levels and reduced expression of intercellular junction proteins.
  • MRP4 represents a potential therapeutic target for conditions involving endothelial barrier dysfunction.